** Shares of Integrated Diagnostics IDHC.L fall as much as
8.1% to a record low of 0.4429p, among top pct losers across all
London bourses
** Middle East and Africa-focused customer healthcare firm
logs annual net profit of 527 mln Egyptian pounds ($17.1 mln),
down 65% due to normalisation of COVID-related sales
** Says FY rev fell 31% to 3.61 bln Egyptian pounds
** IDHC sees 2023 profit margins unchanged, with long-term
margins to normalise after COVID boost in FY21
** Stock on track for worst day since August, if trend holds
** Up to last close, stock down ~24% this year
($1 = 30.8500 Egyptian pounds)
(Reporting by Prerna Bedi in Bengaluru)
((Prerna.Bedi@thomsonreuters.com; +91 98052 24616;))